Enova (ENVA) Insider Filing: Fisher Exercises Options, Sells 25,000 Shares at ~$121.80
Rhea-AI Filing Summary
Enova International insider transactions by CEO/Director David Fisher: The filing shows Mr. Fisher exercised employee stock options and simultaneously sold portions of his shares on August 28-29, 2025. He exercised a total of 25,000 options at an exercise price of $23.96 per share (15,000 on 08/28/2025 and 10,000 on 08/29/2025), increasing beneficial ownership represented by the exercised shares before sales to 363,223 and then 358,223 shares as sales occurred. On the same dates he sold 25,000 shares (15,000 and 10,000) at weighted-average prices of $121.8028 and $121.7989 respectively (execution ranges disclosed in the filing). Post-transactions his direct beneficial ownership is reported as 348,223 shares. The exercised options are non-qualified options with corresponding limited SARs that vest in prior years and expire February 12, 2026. The filing was signed by an attorney-in-fact on September 2, 2025.
Positive
- Exercise of vested options indicates management is receiving long-term compensation that vests over time
- Clear disclosure of execution price ranges and weighted-average sale prices improves transparency
Negative
- Substantial insider sales of 25,000 shares at weighted-average prices near $121.80 reduced the reporting person’s direct holdings to 348,223 shares
- Options expire February 12, 2026, limiting future optionality for the reported grants
Insights
TL;DR: CEO exercised vested options then sold the resulting shares; routine compensation-related liquidity, not necessarily signaling company fundamentals.
The pattern—exercise of vested non-qualified options followed by sales—matches common executive behavior to cover tax liabilities or diversify holdings after vesting. The filing discloses precise exercise prices ($23.96) and weighted-average sale prices (~$121.80) with execution ranges provided for transparency. The presence of limited SARs paired with options is noted; these SARs only become exercisable on specified corporate change events and do not affect current liquidity. This is a standard Section 16 disclosure; absent other context (e.g., sizable additional insider sales or material corporate events), the transactions appear administrative rather than tied to new information about operations.
TL;DR: Materiality is limited—transactions are sizable in nominal dollars but are option-driven and individually routine.
The filing reports the exercise of 25,000 options and concurrent disposition of 25,000 shares at ~ $121.80, which realized substantial proceeds relative to exercise cost ($23.96). Post-transaction direct ownership stands at 348,223 shares. From an investor-impact perspective, these trades are disclosed as required and lack accompanying operational or financial disclosures that would elevate their significance. Investors seeking material signal should compare these trades to historical insider activity and aggregate holdings; this filing alone is neutral in impact.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 10,000 | $0.00 | -- |
| Exercise | Common Stock, par value $0.00001 per share | 10,000 | $23.96 | $240K |
| Sale | Common Stock, par value $0.00001 per share | 10,000 | $121.7989 | $1.22M |
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 15,000 | $0.00 | -- |
| Exercise | Common stock, par value $0.00001 per share | 15,000 | $23.96 | $359K |
| Sale | Common stock, par value $0.00001 per share | 15,000 | $121.8028 | $1.83M |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $121.16 to $122.80. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $121.10 to $122.1638. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options vested in substantially equal one-third increments on each of the following dates: February 12, 2020, February 12, 2021, and February 12, 2022.
